| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |